Navigation Links
Neuralstem President and CEO to Update Ongoing ALS and NSI-189/Major Depressive Disorder Trials at 2012 Biotech Showcase
Date:1/9/2012

llectual property rights. Actual results may differ materially from the results anticipated in these forward-looking statements. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in Neuralstem's periodic reports, including the annual report on Form 10-K for the year ended December 31, 2010 and the  quarterly report on Form 10-Q for the period ended September 30, 2011.


'/>"/>
SOURCE Neuralstem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Neuralstem ALS Stem Cell Trial Featured on Fox Atlanta
2. Neuralstem Receives Notice of Patent Allowance for Spinal Cord Delivery Platform
3. Neuralstem President and CEO to Present at the 2011 Stifel Nicolaus Annual Healthcare Conference
4. Neuralstem Awarded Department of Defense Contract for Brain Cancer Research
5. Neuralstem Reports First Quarter Financial Results and Provides Business and Clinical Update
6. Former Capital One Director and Business Leader Stanley I. Westreich Joins Neuralstems Board
7. Neuralstem, Inc. Settles Litigation Against ReNeuron, Ltd.
8. Neuralstem, Inc. to Present At World Stem Cells and Regenerative Medicine Congress
9. Neuralstem Completes $5.25 Million Financing
10. Neuralstem, Inc. Reports Third Quarter Financial Results and Provides Business Update
11. Neuralstem Receives FDA Approval to Commence First ALS Stem Cell Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... BREA, Calif. , June 19, 2013  Continuing ... of myocardial infarction (MI), Beckman Coulter , Inc. ... clearance of its new Access AccuTnI+3 troponin I assay ... "Clinicians have depended on Beckman Coulter,s ... the new AccuTnI+3 assay has the proven performance to ...
(Date:6/19/2013)... Biotechnology industry pioneer Amgen (NASDAQ: ... BlackLine Systems  and enterprise application software leader ... webinar next week entitled "No Account Left Behind!  ... to Help Keep Its Account Reconciliations in Good Shape ... The webinar, geared at finance, accounting, audit and compliance ...
(Date:6/19/2013)... Applied Rigaku Technologies, Inc. is pleased ... measurement of sulfur in ultra-low sulfur diesel (ULSD) using ... EDXRF analyzer . The analysis detailed in Rigaku Application ... This International Standard specifies an energy dispersive X-ray ... content in automotive gasoline. , Regulations around the world ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 Tabletop SEMs ... size SEMs but have limited performance and capability such ... Full size SEMs would normally provide better imaging performance ... to operate and have a higher cost of maintenance. ... the gap between these two types of SEM product, ...
Breaking Biology Technology:Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 3Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 2Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 3Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 4Rigaku Publishes New Application Note for Analysis of ULSD Per ISO 13032 2Nanounity Introduces the Pemtron Range of Compact Scanning Electron Microscopes 2Nanounity Introduces the Pemtron Range of Compact Scanning Electron Microscopes 3
... ways to improve infrared photodetector technology that is critical ... used increasingly in commercial applications and consumer products. ... in the journal Applied Physics Letters ... be done more effectively by using certain materials arranged ...
... N.J., Feb. 14, 2012 Laureate Biopharmaceutical ... and manufacturing organization, today announced the appointment ... He will be responsible for continuing Laureate,s ... This will include preparing for upcoming pre-approval ...
... The Foundation for Angelman Syndrome Therapeutics (FAST) announces ... a potential treatment for the rare genetic disorder, Angelman ... Angelman Syndrome study will examine if the off ... symptoms associated with Angelman Syndrome. Minocycline, an FDA approved ...
Cached Biology Technology:New nano-material combinations produce leap in infrared technology 2New nano-material combinations produce leap in infrared technology 3Laureate Biopharma Appoints Les Mintzmyer, Vice President, Operations 2Laureate Biopharma Appoints Les Mintzmyer, Vice President, Operations 3Foundation for Angelman Syndrome Therapeutics (FAST) Funds Human Clinical Trial 2Foundation for Angelman Syndrome Therapeutics (FAST) Funds Human Clinical Trial 3
(Date:6/19/2013)... at the University of Pittsburgh has developed antibacterial ... that could be potential treatments for drug-resistant bacterial ... new agents are quite small, making them inexpensive ... in the June 2013 issue of the journal ... first of many probable applications will likely be ...
(Date:6/19/2013)... June 19, 2013 A decade-long JDRF-funded study ... Helmholtz Zentrum Mnchen, Germany, is providing a deeper ... risk of developing type 1 diabetes (T1D), highlighting ... for the disease. The study, "Seroconversion to Multiple ... in Children," was published today in The ...
(Date:6/19/2013)... how pearls form into the most perfectly spherical large ... are proposing in a new study. It appears in ... Laureate Irving Langmuir. , Julyan Cartwright, Antonio G. Checa ... and highly prized pearls have perhaps the most perfectly ... nature that are visible without a microscope. Pearls develop ...
Breaking Biology News(10 mins):HIV-derived antibacterial shows promise against drug-resistant bacteria 2New data on islet autoantibodies in young children defines early type 1 diabetes development 2
... your bananas are more than pests—they may be allies ... caused when genes malfunction. , "One common misconception is ... a gene for cancer," explains James Erickson, a biology ... the same genes, but individual genes have different forms, ...
... 50 million people died during a worldwide influenza pandemic ... influenza virus. Recently H5N1, another highly infectious avian strain ... There is great concern that this virus might also ... pandemic. Specific mutations in a viral protein, the polymerase, ...
... Media Lab have invented a way to reversibly silence ... prospect of controlling the haywire neuron activity that occurs ... Such diseases often must be treated by removing neurons ... to the development of optical brain prosthetics to control ...
Cached Biology News:Fruit fly gene research may shed light on human disease processes 2Fruit fly gene research may shed light on human disease processes 3A first glimpse of the influenza replication machine 2MIT: Pulsing light silences overactive neurons 2
PGD2-d4 contains 4 deuterium atoms at the 3, 3', 4, and 4' positions. It is intended for use as an internal standard for the quantification of PGD2 by GC- or LC-mass spectrometry....
Request Info...
...
Human Aminopeptidase P1/XPNPEP1 Affinity Purified PAb Protein Family: Aminopeptidases, Metalloproteases...
Biology Products: